MediWound (MDWD) Non-Current Assets (2016 - 2026)
MediWound (MDWD) posted quarterly Non-Current Assets of $26.3 million for Q4 2025, up 23.24% year-over-year from $21.3 million in Q4 2024, and up 5.63% quarter-over-quarter from $24.9 million in Q3 2025.
MediWound (MDWD) Non-Current Assets (2016 - 2026) Analysis & Trends
MediWound's Non-Current Assets history runs 10 years deep, the most recent figure standing at $26.3 million for Q4 2025.
- In Q4 2025, Non-Current Assets rose 23.24% year-over-year to $26.3 million; the TTM figure through Dec 2025 stood at $26.3 million (up 23.24% YoY), while the FY2025 annual figure was $26.3 million, up 23.24% from the prior year.
- Non-Current Assets for Q4 2025 stood at $26.3 million, up from $24.9 million in the prior quarter.
- The five-year high for Non-Current Assets was $26.3 million in Q4 2025, with the low at $4.1 million in Q3 2022.
- The 5-year median for Non-Current Assets is $10.0 million (2023), against an average of $12.8 million.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets slipped 12.85% in 2022, then surged 301.44% in 2023.
- MediWound's Non-Current Assets stood at $4.8 million in 2021, then slipped by 12.85% to $4.2 million in 2022, then soared by 301.44% to $16.8 million in 2023, then gained by 27.25% to $21.3 million in 2024, then increased by 23.24% to $26.3 million in 2025.
- Business Quant data shows MDWD's Non-Current Assets at $26.3 million in Q4 2025, $24.9 million in Q3 2025, and $23.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 938.60 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 468.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 18.06 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 6.80 Bn |
| 10 | MediWound | 169.29 Mn | 138.30 Mn | 337,000.00 | 28.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.93 Mn |
| Dec 31, 2025 | 26.29 Mn |
| Sep 30, 2025 | 24.89 Mn |
| Jun 30, 2025 | 23.92 Mn |
| Mar 31, 2025 | 21.99 Mn |
| Dec 31, 2024 | 21.33 Mn |
| Sep 30, 2024 | 20.85 Mn |
| Jun 30, 2024 | 19.98 Mn |
| Mar 31, 2024 | 18.18 Mn |
| Dec 31, 2023 | 16.76 Mn |
| Sep 30, 2023 | 13.77 Mn |
| Jun 30, 2023 | 6.31 Mn |
| Mar 31, 2023 | 5.40 Mn |
| Dec 31, 2022 | 4.18 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 4.30 Mn |
| Mar 31, 2022 | 4.41 Mn |
| Dec 31, 2021 | 4.79 Mn |
| Sep 30, 2021 | 4.50 Mn |
| Jun 30, 2021 | 4.68 Mn |